Lv12
40 积分 2025-08-24 加入
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
1小时前
已完结
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
2小时前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
17小时前
已完结
皖公网安备34019202002308
